Betere controle en behandeling van immuun-gemedieerde ziekten door het universum van door micro-omgeving opgelegde weefselsignaturen en hun correlaten in vloeibare biopten te verkennen KU Leuven
mmune-mediated diseases (IMIDs) are an increasing medical burden in industrialized countries worldwide. IMIDs are characterized by an enormous heterogeneity with regard to disease outcome and response to targeted therapies, which currently cannot be adequately anticipated to tailor individual patient management. Hence, mechanistic understanding of this heterogeneity and biomarkers predictive for disease control and therapy response over time ...